Description

Ypsomed Holding AG, along with its affiliates, specializes in the design, production, and sale of advanced injection and infusion delivery systems for pharmaceutical and biotechnology enterprises. The company structures its activities into two main divisions: Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment offers a broad array of innovative injection devices, including pen, auto, patch, and wearable injectors, as well as other smart medical technologies, all marketed under the YDS brand. Meanwhile, the Ypsomed Diabetes Care division is dedicated to providing vital products for diabetes management, such as insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, and various daily essentials, all sold under the mylife brand. Furthermore, the company extends its services to include precision turned parts and contract manufacturing. Its diverse product range is distributed through strategic partnerships with biotech and pharma companies, its own distribution infrastructure, and independent distributors. Established in 1984 and headquartered in Burgdorf, Switzerland, Ypsomed Holding AG maintains a significant presence across Switzerland, Europe, North America, and other international regions.